Amgen Inc. Blog | Talkmarkets

Latest Posts

3 Promising Oncology Stocks To Consider Adding To Your Portfolio

Article By: StockNews

Monday, June 14, 2021 12:31 AM EDT

With tech integration and DNA sequencing increasing the efficacy of potential cancer drugs in the pipeline, we believe biotech names AstraZeneca, Amgen and Incyte are worth adding to a portfolio.

In this article: AZN, INCY, AMGN Also: SPY, CNCR

Read

4 Biotech Stocks To Buy For The Q2 2021

Article By: StockNews

Monday, April 5, 2021 6:45 AM EDT

The global biotechnology market is expected to expand at a CAGR of 15.8% between 2021 – 2028.

In this article: JAZZ, AMGN, GILD, QGEN

Read

10 Dividend Growth Stocks To Beat The Market

Video By: Chuck Carnevale

Friday, March 26, 2021 11:52 AM EDT

There are many detractors that believe that dividend growth stock investing is stodgy, old, and boring.

In this video: CDNAF, ABC, LMT, MO, AMGN, ORCL, TROW, ANTM, MTRAF, OTEX, SPX

Watch

How Will Biotech ETFs React To These Q4 Earnings Releases?

Article By: Zacks Investment Research

Saturday, February 6, 2021 4:47 PM EDT

Any positive news highlighting the progress of vaccine or antibody manufacturers is expected to create great returns for investors. Let’s take a look at some biotechnological earnings releases to see if these will impact ETFs exposed to the space.

In this article: BBH, IBB, XBI, BIIB, ALXN, GILD, AMGN

Read